New technology aimed at stopping degenerative cerebral dysfunctions

22 November 2022

Marchmont Innovation News

Researchers in St. Petersburg have come up with what they say is an “effectual” drug candidate to treat Alzheimer’s related degenerative cerebral dysfunctions. The St. Petersburg Institute of Bioregulation and Gerontology and the Pavlov Institute of Physiology are behind the research effort.

As they experimented with Alzheimer’s mouse models, the scientists found out that using special peptides could help prevent and even reverse in the test mice’s brains the loss of what physiologists refer to as dendritic spines – special postsynaptic structures that are responsible for memory mechanisms and particularly involved in forming new memories – thus having cerebral functions fully restored.

The peptide candidate is considered “unique” and safe as no side effects have been reported.



Our news

All news

Media Center

Read more